Serum Dickopff 1 as a Novel Biomarker in Hepatocellular Carcinoma Diagnosis and Follow Up After Ablative Therapy

References

• Liu AM, Yao TG, Wang W, et al. Circulating miR-15b and miR- 130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open. 2012;2:e000825.
   PubMed Web of Science ®Google Scholar
• El-Zayadi AR, Badran HM, Barakat EM, et al. Hepato cellular carcinoma in Egypt: a single centre study over a decade. World J Gastroenterol. 2005;11(33):5193–5198. doi:10.3748/wjg.v11.i33.519316127751
   PubMed Web of Science ®Google Scholar
• Negm O, AbouSaif S, El Gharib M, et al. Role of low-molecular-weight heparins in prevention of thromboembolic complication after transarterial chemoembolization in hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2017;29(3):317–321. doi:10.1097/MEG.000000000000079027893491
   PubMed Web of Science ®Google Scholar
• Elwan N, Salem ML, Kobtan A, et al. High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients. Immunol Invest. 2018;47(2):169–180. doi:10.1080/08820139.2017.140778729182438
   PubMed Web of Science ®Google Scholar
• Abdelfattah AAM, Rizk F, Hawash N, et al. Randomized trial of preoperative administration of oral pregabalin for postoperative analgesia in patients scheduled for radiofrequency ablation of focal lesions in the liver. Int J Hyperthermia. 2018;34(8):1367–1371. doi:10.1080/02656736.2018.142494629308685
   PubMed Web of Science ®Google Scholar
• Aghoram R, Cai P, Dickinson JA. Alpha-foeto protein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B. Cochrane Database Syst Rev. 2012;9:CD002799.
   Google Scholar
• Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519–524. doi:10.1053/jhep.2002.3208911870363
   PubMed Web of Science ®Google Scholar
• IuS T. Detection of embryo-specific alpha-globulin in the blood serum of a patient with primary liver cancer. Vopr Med Khim. 1964;10:90–91.14207501
   PubMedGoogle Scholar
• Zhou L, Liu J, Luo F. Serum tumor markers for detection of hepatocellularcarcinoma. World J Gastroenterol. 2006;12:1175–1181. doi:10.3748/wjg.v12.i8.117516534867
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Marrero JA, Rudolph L, et al. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134:1752–1763. doi:10.1053/j.gastro.2008.02.09018471552
   PubMed Web of Science ®Google Scholar
• Yu B, Yang X, Xu Y, et al. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. J Hepatol. 2009;50:948–957. doi:10.1016/j.jhep.2008.11.02019303159
   PubMed Web of Science ®Google Scholar
• Shen Q, Fan J, Yang XR, et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol. 2102;13:817–826. doi:10.1016/S1470-2045(12)70233-4
   PubMed Web of Science ®Google Scholar
• Zahran F, Barakat L, Radwan N, et al. Comparative study betweeN DKK-1 and AFP FOR diagnosing of hepatocellular carcinoma among Egyptian patients. ejpmr. 2016;3(9):20–27.
   Google Scholar
• Erdal H, Utku OG, Karatay E, Celik B, Elbeg S, Doğan I. Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone. Turk J Gastroenterol. 2016;27:375–381. doi:10.5152/tjg27458854
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhao Y, Yang Q. Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis. Int J Biol Markers. 2014;29(4):e403e410. 24. doi:10.5301/jbm.5000101
   Web of Science ®Google Scholar
• Prieto PA, Charles H. DKK1 as a serum biomarker for hepatocellular carcinoma. HepatobiliarySurgNutr. 2013;2(3):127–128.
   Google Scholar
• Sharaf A, El-Badrawy EL, Khalifa N, et al. Dickkopf-1: as a diagnostic and prognostic serum marker for hepatocellular carcinoma. Afro-Egypt J Infect Endem Dis. 2016;6(4):156–165.
   Google Scholar
• Tung EK, Mak CK, Fatima S, et al. Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma. Liver Int. 2011;31:1494–1504. doi:10.1111/j.1478-3231.2011.02597.x21955977
   PubMed Web of Science ®Google Scholar
• Yang H, Chen GD, Fang F, et al. Dickkopf-1: as a diagnostic and prognostic serum marker for early hepatocellular carcinoma. Int J Biol Markers. 2013;28(3):286297. doi:10.5301/JBM.5000015
   Web of Science ®Google Scholar
• Fouad YM, Mohamed HI, Kamal EM, et al. Clinical significance and diagnostic value of serum Dickkopf-1 in patients with hepatocellular carcinoma. Scand J Gastroenterol. 2016;51(9):1133–1137. doi:10.3109/00365521.2016.117233727161933
   PubMed Web of Science ®Google Scholar
• Beppu T, Sugimoto K, Shiraki K, et al. Clinical significance of tumor markers in detection of recurrent hepatocellular carcinoma after radiofrequency ablation. Int J Mol Med. 2010;26(3):425–433.20664960
   PubMed Web of Science ®Google Scholar
• Kim SU, Park JH, Kim HS, et al. Serum Dickkopf-1 as a biomarker for the diagnosis of hepatocellular carcinoma. Yonsei Med J. 2015;56(5):1296–1306. doi:10.3349/ymj.2015.56.5.129626256972
   PubMed Web of Science ®Google Scholar
• Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology. 2010;78(Suppl 1):113–124. doi:10.1159/00031523920616593
   PubMed Web of Science ®Google Scholar
• Zhao Y, Gao Q, Pei L, et al. Currentstatus and future prospects of biomarkers in the diagnosis of hepatocellular carcinoma. Int J Biol Markers. 2017;32(4):e361–e369. doi:10.5301/ijbm.500029928967065
   PubMed Web of Science ®Google Scholar
• Chan S, Mo F, Philip J, et al. Performance of serum a-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass. HPB. 2014;16:366–367. doi:10.1111/hpb.1214623980880
   PubMed Web of Science ®Google Scholar